Trend in cervical cancer screening in Spain (2003-2009) and predictors of adherence

European Journal of Cancer Prevention

Volumn 21, Issue 1, 2012, Pages 82-88

  Martín López, Rocío ^a   Hernández Barrera, Valentín ^a   De Andres, Ana Lopez ^a   Carrasco Garrido, Pilar ^a   De Miguel, Angel Gil ^a   Jimenez Garcia, Rodrigo ^a  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

Author keywords

Adherence; Compliance; Mass screening; Pap smear; Trends; Uterine cervical neoplasm; Vaginal smears

Indexed keywords

ADULT; AGE; ARTICLE; CANCER SCREENING; CHRONIC DISEASE; EDUCATIONAL STATUS; FEMALE; HUMAN; INCOME; LIFESTYLE; MUSCULOSKELETAL DISEASE; OBESITY; PAPANICOLAOU TEST; PATIENT COMPLIANCE; PRIORITY JOURNAL; SPAIN; UTERINE CERVIX CANCER;

ADULT; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PATIENT COMPLIANCE; PROGNOSIS; SPAIN; TIME FACTORS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 82555195635     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32834a7e46     Document Type: Article

References (45)

1. Anttila A, Ronco G, Clifford G, Bray F, Hakama M, Arbyn M, et al. (2004). Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer 91:935-941. (Pubitemid 39273788)
2. Anttila A, Ronco G, Lynge E, Fender M, Arbyn M, Baldauf JJ, et al. (2008). Chapter 2: epidemiological guidelines for quality assurance in cervical cancer screening. In: Arbyn M, Anttila A, Jordan J, Fender M, Arbyn M, Baldauf JJ, et al., editors. European guidelines for quality assurance in cervical cancer screening. 2nd ed. Luxembourg: Office for Official Publications of the European Communities. pp. 11-52.
3. Anttila A, Karsa L, Aasmaa A, Fender M, Patnick J, Rebolj M, et al. (2009). Cervical cancer screening policies and coverage in Europe. Eur J Cancer 45:2649-2658.
4. Arbyn M, Raifu AO, Bray F, Weiderpass E, Anttila A (2009). Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer 45:2640-2648.
5. Ascunde N, Salas D, Zubizarreta R, Almazán R, Ibáñez J, Ederra M (2010). Cancer screening in Spain. Ann Oncol 21:iii43-iii51.
6. Bray F, Loos AH, McCarron P, Weiderpass E, Arbyn M, Moller H, et al. (2005). Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 14:677-686. (Pubitemid 40489214)
7. Byrne M, Davila EP, Zhao W, Parker D, Hooper MW, Caban-Martinez A, et al. (2010). Cancer screening behaviors among smokers and non-smokers. Cancer Epidemiol 34:611-617.
8. Cabeza E, Esteva M, Pujol A, Thomas V, Sánchez-Contador C (2007). Social disparities in breast and cervical cancer preventive practices. Eur J Cancer Prev 16:372-379. (Pubitemid 47165304)
9. Cancer Strategy of Spanish Ministry of Health (2011). Available at: http://www.msps.es/organizacion/sns/planCalidadSNS/pdf/ ActualizacionEstrategiaCancer.pdf [Accessed 4 January 2011]
10. Corté s J, Martinón-Torres F, Ramón y Cajal JM, Gil A, Velasco J, Abizanda M, et al. (2010). Primary and secondary prevention of cancers of the cervix and vulva: recommendations for clinical practice. Prog Obstet Ginecol 53 (Supl.1):1-19.
11. Council of the European Union (2003). Council Recommendation of 2 December 2003 on cancer screening (2003/878/EC). Off J Eur Union L327:34-38.
12. Coughlin SS, Uhler RJ, Hall HI, Briss PA (2004). Nonadherence to breast and cervical cancer screening: what are the linkages to chronic disease risk? Prev Chronic Dis 1:A04.
13. Coughlin SS, Breslau ES, Thompson T, Benard VB (2005). Physician recommendation for Papanicolaou testing among US women, 2000. Cancer Epidemiol Biomarkers Prev 14:1143-1148. (Pubitemid 40656459)
14. Coughlin SS, Leadbetter S, Richards T, Sabatino SA (2008). Contextual analysis of breast and cervical cancer screening and factors associated with healthcare access among United States women 2002. Soc Sci Med 6:260-275. (Pubitemid 350236484)
15. European Commission (2011). Eurostat. European health interview survey (EHIS) Available at: http://epp.eurostat.ec.europa.eu/cache/ITY-SDDS/EN/hlth- ehis-esms.htm. [Accessed 3 February 2011]
16. Ferlay J, Parkin DM, Steliarova-Foucher E (2010). Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765-781.
17. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917.
18. Ferrante JM, Chen PH, Crabtree BF,Warternberg D (2007). Cancer screening in women: body mass index and adherence to physician recommendations. Am J Prev Med 32:525-531. (Pubitemid 46805196)
19. Forbes C, Jepson R, Martin-Hirsch P (2002). Intervetions targeted at women to encourage the uptake of cervical screening. Cochrane Database Syst Rev 3:CD002834.
20. Galán I, Rodríguez-Artalejo F, Díez- Gañán L, Tobías A, Zorrilla B, Gandarillas A (2006). Clustering of behavioural risk factors and compliance with clinical preventive recommendations in Spain. Prev Med 42:343-347. (Pubitemid 43729960)
21. Gök M, Heideman DA, Van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JW, et al. (2010). HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 340:c1040.
22. Hewitt M, Devesa SS, Breen N (2004). Cervical cancer screening among US women: analyses of the 2000 National Health Interview Survey. Prev Med 39:270-278. (Pubitemid 38834016)
23. Howard M, Agarwal G, Lytwyn A (2009). Accuracy of self-reports of pap and mammography screening compared to medical record: a meta-analysis. Cancer Causes Control 20:1-13.
24. Ministry of Health. Human Papilloma virus. Actual situation, vaccines and future perspectives of use. [Virus del papiloma humano. Situacion actual, vacunas y perspectivas de su utilizacion] Available at: http://www.msps.es/ profesionales/saludPublica/prevPromocion/vacunaciones/docs/VPH-2007.pdf [Accesed 30 March 2011]
25. Ministry of Health. Vaccination coverages. [Coberturas de vacunacion] Available at: http://www.msps.es/profesionales/saludPublica/prevPromocion/ vacunaciones/coberturas.htm [Accessed 30 March 2011]
26. Insituto Nacional de Estadística. 2011 Encuesta Europea de Salud para España. Available at: http://www.ine.es/metodologia/t15/t153042009. pdf. [Accessed 3 February 2011]
27. International Agency for Research on Cancer (1986). Screening for cancer of the uterine cervix. From the IARC working group on cervical cancer screening and the UICC project group on the evaluation of screening programmes for cancer. IARC Sci Publ. pp. 1-315.
28. International Agency for Research on Cancer (2005). Cervix cancer screening. IARC Handbooks of Cancer Prevention, vol 10. Lyon: IARC Press. pp. 1-302.
29. Johnson CE, Mues KE, Mayne SL, Kiblawi AN (2008). Cervical cancer screening among immigrants and ethnic minorities: a systematic review using the Health Belief Model. J Low Genit Tract Dis 12:232-241.
30. Kiefe C, Funkhouser E, Fouad MN, May DS (1998). Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med 13:357-365. (Pubitemid 28294713)
31. Luengo Matos S, Munëoz van den Eynde A (2004). Use of pap smear for cervical cancer screening and factors related with its use in Spain. Aten Primaria 33:229-234. (Pubitemid 38684752)
32. Martín-López R, Hernández-Barrera V, López De Andres A, Carrasco-Garrido PC, Gil-De Miguel A, Jimenez-García R (2010). Breast and cervical cancer screening in Spain and predictors of adherence. Eur J Cancer Prev 19:239-245.
33. Maruthur NM, Bolen SD, Brancati FL, Clark JM (2009). The association of obesity and cervical cancer screening: a systematic review and meta-analysis. Obesity 17:375-381.
34. Mathers CD, Boerma T, Ma Fat D (2008). The Global Burden of Disease: 2004 update. Geneva: World Health Organization.
35. Miller AB (2002). The (in)efficienciy of cervical screening in Europe. Eur J Cancer 38:321-326.
36. Mitchell RS, Padwal RS, Chuck AW, Klarenbach SW (2008). Cancer screening among the overweight and obese in Canada. Am J Prev Med 35:127-132. (Pubitemid 351915789)
37. Nelson W, Moser RP, Gaffey A, Waldron W (2009). Adherence to cervical cancer screening guidelines for US women aged 25-64: data from the 2005 Health Information National Trends Survey (HINTS). J Womens Health (Larchmt) 18:1759-1768.
38. Nicula FA, Anttila A, Neamtiu L, Zakelj MP, Tachezy R, Chil A, et al. (2009). Challenges in starting organised screening programmes for cervical cancer in the new member states of the European Union. Eur J Cancer 45:2679-2684.
39. Oliva J, Lobo F, López-Bastida J, Zozaya N, Romay R (2005). Indirect costs of cervical and breast cancers in Spain. Eur J Health Econ 6:309-313. (Pubitemid 41779929)
40. Palencia L, Espelt A, Rodriguez-Sanz M, Puipinós R, Pons-Vigué s M, Pasarín MI, et al. (2010). Socio-economic and inequalities in breast and cervical cancer screening practices in Europe: influence of the type of screening program. Int J Epidemiol 39:757-765.
41. Peto J, Gilham C, Fletcher O, Matthews FE (2004). The cervical cancer epidemic that screening has prevented in UK. Lancet 346:249-256. (Pubitemid 38942814)
42. Puig-Tintoré LM, Castellsagué X, Torné A, de Sanjosé S, Corté s J, Roura E, et al. (2008). Coverage and factors associated with cervical cancer screening: results from the AFRODITA study: a population-based survey in Spain. J Low Genit Tract Dis 12:82-89. (Pubitemid 351457912)
43. Spaczynski M, Karowicz-Bilinska A, Rokita W, Molinska-Glura M, Januszek- Michalecka L, Seroczynski P, et al. (2010). Attendance rate in the Polish cervical cancer screening program in the years 2007-2009. Ginekol Pol 81:655-663.
44. Spadea T, Bellini S, Kunst A, Stirbu I, Costa G (2010). The impact of interventions to improve attendance in female cancer screening among lower socioeconomic groups: a review. Prev Med 50:159-164.
45. Virtanen A, Anttila A, Luostarinen T, Nieminen P (2010). Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland. Int J Cancer 28:(Epub ahead of print).